IL261536A - Therapy and prophylaxis of infectious disease caused by zika virus - Google Patents

Therapy and prophylaxis of infectious disease caused by zika virus

Info

Publication number
IL261536A
IL261536A IL261536A IL26153618A IL261536A IL 261536 A IL261536 A IL 261536A IL 261536 A IL261536 A IL 261536A IL 26153618 A IL26153618 A IL 26153618A IL 261536 A IL261536 A IL 261536A
Authority
IL
Israel
Prior art keywords
prophylaxis
therapy
infectious disease
disease caused
zika virus
Prior art date
Application number
IL261536A
Other languages
Hebrew (he)
Other versions
IL261536B (en
Inventor
Eran Schenker
Yuval Sagiv
Original Assignee
Kamada Ltd
Eran Schenker
Yuval Sagiv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamada Ltd, Eran Schenker, Yuval Sagiv filed Critical Kamada Ltd
Publication of IL261536A publication Critical patent/IL261536A/en
Publication of IL261536B publication Critical patent/IL261536B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL261536A 2016-03-03 2017-02-27 Therapy and prophylaxis of infectious disease caused by zika virus IL261536B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662302842P 2016-03-03 2016-03-03
PCT/IL2017/050243 WO2017149528A1 (en) 2016-03-03 2017-02-27 Intrauterine therapy and prophylaxis of infectious diseases in a mammal fetus

Publications (2)

Publication Number Publication Date
IL261536A true IL261536A (en) 2018-10-31
IL261536B IL261536B (en) 2022-07-01

Family

ID=59743561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL261536A IL261536B (en) 2016-03-03 2017-02-27 Therapy and prophylaxis of infectious disease caused by zika virus

Country Status (3)

Country Link
BR (2) BR112018067353A2 (en)
IL (1) IL261536B (en)
WO (1) WO2017149528A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113429479B (en) * 2018-04-04 2023-03-10 中国科学院微生物研究所 High-sensitivity yellow fever virus humanized monoclonal antibody and application thereof
CA3104603A1 (en) * 2018-06-21 2019-12-26 Emergent Biosolutions Canada Inc. Zika neutralizing antibody compositions and methods of using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases

Also Published As

Publication number Publication date
WO2017149528A1 (en) 2017-09-08
IL261536B (en) 2022-07-01
BR132018069012E2 (en) 2020-04-07
BR112018067353A2 (en) 2019-01-15

Similar Documents

Publication Publication Date Title
HK1251554A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
HK1248711A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
SG10201913630YA (en) Zika virus vaccine
HK1223931A1 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
HUE061679T2 (en) Zika virus vaccine
HK1247636A1 (en) Rna guided eradication of human jc virus and other polyomaviruses
HK1219480A1 (en) 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection 6-
IL244431A0 (en) Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
GB201613191D0 (en) Zika virus vaccine
HK1231402A1 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections b d
HK1251265A1 (en) Diagnosis and treatment of infectious disease
HK1222653A1 (en) Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection --
EP3484511A4 (en) Vaccine compositions for treatment of zika virus
HUE044606T2 (en) Treatment of hepatitis delta virus infection
IL261536A (en) Therapy and prophylaxis of infectious disease caused by zika virus
SG11201605440TA (en) Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome
EP3420076C0 (en) Methods of producing and characterizing virus vaccine and virus vaccine composition
HK1222855A1 (en) Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection --
ZA201805989B (en) Compositions and methods of treatment of chronic infectious diseases
PT3393510T (en) Zika virus vaccine
RS65250B1 (en) Preparation for the treatment and/or prophylaxis of inflammatory infectious diseases
GB201509753D0 (en) Production of a crimean-congo haemorrhagic fever virus diagnostic and vaccine composition
AU2016901650A0 (en) Method of Prophylaxis of Zika Virus Infection
GB201510882D0 (en) Diagnosis and treatment of infectious disease
GB201510879D0 (en) Diagnosis and treatment of infectious disease